Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

Christine Federspiel; Theis S Itenov; Katrin Thormar; Morten H Bestle

Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

Christine Federspiel, Theis S Itenov, Katrin Thormar, Morten H Bestle

Institut for Klinisk Medicin

1 Citationer (Scopus)

Abstract

Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.

Bidragets oversatte titel	Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients
Originalsprog	Dansk
Artikelnummer	V07150610
Tidsskrift	Ugeskrift for Laeger
Vol/bind	177
Udgave nummer	50
Sider (fra-til)	2-6
Antal sider	5
ISSN	0041-5782
Status	Udgivet - 7 dec. 2015

Adgang til dokumentet

http://ugeskriftet.dk.ep.fjernadgang.kb.dk/videnskab/V07150610

Citationsformater

@article{206cccd6369d40efb4e62666eed3cf71,

title = "Begr{\ae}nset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter",

abstract = "Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.",

author = "Christine Federspiel and Itenov, {Theis S} and Katrin Thormar and Bestle, {Morten H}",

year = "2015",

month = dec,

day = "7",

language = "Dansk",

volume = "177",

pages = "2--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "50",

}

TY - JOUR

T1 - Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

AU - Federspiel, Christine

AU - Itenov, Theis S

AU - Thormar, Katrin

AU - Bestle, Morten H

PY - 2015/12/7

Y1 - 2015/12/7

N2 - Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.

AB - Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.

M3 - Tidsskriftartikel

C2 - 26651912

SN - 0041-5782

VL - 177

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 50

M1 - V07150610

ER -

Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater